Advertisement
Product › Details
Heparesc®
Next higher product group | cell therapy product_oo | |
Status | 2016-04-18 development existent | |
Organisation | Promethera Biosciences S.A. | |
Group | Promethera (Group) | |
Organisation 2 | Cytonet GmbH & Co. KG | |
Group | Promethera (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for cell therapy product_oo
- [1] Sernova Corporation. (1/10/23). "Press Release: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes". London, ON....
- [2] Evotec SE. (5/17/22). "Press Release: Evotec and Sernova Announce Exclusive Strategic Partnership for iPSC-based Beta Cell Replacement Therapy to Advance a 'Functional Cure' for Diabetes". Hamburg & London, ON....
- [3] Bone Therapeutics S.A.. (3/26/20). "Press Release: Bone Therapeutics Appoints Stefanos Theoharis as Chief Business Officer". Gosselies....
- [4] Kiadis Pharma N.V.. (8/25/17). "Press Release: Kiadis Pharma Announces Financial Results for the Six Months ended June 30, 2017". Amsterdam-Duivendrecht....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top